OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients.
暂无分享,去创建一个
[1] Jason M. White,et al. OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence , 2011, Pharmacogenetics and genomics.
[2] G. Jenkins,et al. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. , 2010, The American journal of psychiatry.
[3] D. Couper,et al. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. , 2009, Alcoholism, clinical and experimental research.
[4] D. Couper,et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. , 2008, Archives of general psychiatry.
[5] L. Ray,et al. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. , 2007, Archives of general psychiatry.
[6] R. Rosenheck,et al. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. , 2007, Alcoholism, clinical and experimental research.
[7] Robert A Koeppe,et al. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. , 2006, Archives of general psychiatry.
[8] R. Feinn,et al. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. , 2006, Drug and alcohol dependence.
[9] D. Oslin,et al. A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients , 2003, Neuropsychopharmacology.
[10] J A Tischfield,et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Oslin,et al. A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients , 2008, Psychopharmacology.
[12] D. Oslin,et al. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. , 2003, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.